Early administration of the second dose of surfactant (beractant) in the treatment of severe hyaline membrane disease

Acta Paediatrica, International Journal of Paediatrics

Volumn 90, Issue 3, 2001, Pages 296-301

  Figueras Aloy, J ^a   Quero, J ^a   Carbonell Estrany, X ^a   Ginovart, G ^a   Perez Rodriguez J ^a   Raspall, F ^a   Rodriguez Miguelez J M ^a   Salvia M D ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Beractant; Exogenous surfactant; Hyaline membrane disease; Premature infants

Indexed keywords

ALBUMIN; ARTIFICIAL LUNG SURFACTANT; DOPAMINE; LUNG SURFACTANT EXTRACT;

AIRWAY PRESSURE; ARTERIAL OXYGEN TENSION; ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG EFFICACY; FEMALE; GESTATIONAL AGE; HUMAN; HYALINE MEMBRANE DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

BIOLOGICAL PRODUCTS; FEMALE; HUMANS; HYALINE MEMBRANE DISEASE; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PROSPECTIVE STUDIES; PULMONARY SURFACTANTS;

EID: 0035045795     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2001.tb00308.x     Document Type: Article

References (20)

1. Comparison of Infasurf (calf lung surfactant extract) to Survanta (beractant) in the treatment and prevention of respiratory distress syndrome
2. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome
3. Comparison of two strategies for surfactant prophylaxis in very premature infants: A multicenter randomized trial
4. Lung surfactant and the pathogenesis of neonatal bronchiolar lesions induced by artificial ventilation
5. Principles of surfactant replacement
6. Surfactant dysfunction makes lungs vulnerable to repetitive collapse and reexpansion
7. Lung function in premature infants can be improved. Surfactant therapy and CPAP reduce the need of respiratory support
8. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation
9. Surfactant nebulization versus instillation during High frequency ventilation in surfactant-deficient rabbits
10. Surfactant replacement therapy: A multicenter trial comparing two dosage approaches
11. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs
12. Respiratory Distress Syndrome
13. Prophylactic versus selective use of surfactant for preventing morbidity and mortality in preterm infants
14. Early or selective surfactant (Colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation: A European double-blind trial with sequential analysis
15. Early versus late surfactant treatment in preterm infants of 27 to 32 weeks' gestational age: A multicenter controlled clinical trial
16. A prospective randomized trial of early versus late administration of a single dose of surfactant-TA
17. Early versus delayed neonatal administration of a synthetic surfactant - The judgement of OSIRIS
18. Surfactant function in respiratory distress syndrome
19. Systematic review of prophylactic versus rescue surfactant
20. Surfactant. Evolving issues